| Medication errors associated with adverse drug reactions in Iran (2015-2017): A P-method approach Z Karimian, M Kheirandish, N Javidnikou, G Asghari, F Ahmadizar, ... International journal of health policy and management 7 (12), 1090, 2018 | 37 | 2018 |
| Evaluation of COVID-19 vaccine effectiveness in a changing landscape of COVID-19 epidemiology and vaccination: interim guidance, 1 October 2022: second addendum to evaluation … World Health Organization World Health Organization, 2022 | 14 | 2022 |
| The quality of reporting general safety parameters and immune-related adverse events in clinical trials of FDA-approved immune checkpoint inhibitors Z Karimian, S Mavoungou, JE Salem, F Tubach, A Dechartres BMC cancer 20, 1-11, 2020 | 11 | 2020 |
| The shifting landscape of pharmaceutical care–during and beyond the COVID-19 pandemic Z Karimian, K Gholami Journal of Pharmaceutical Care, 2020 | 7 | 2020 |
| Delayed infusion reactions to enzyme replacement therapies Z Karimian, CB Whitley, KD Rudser, JRJ Utz JIMD Reports, Volume 34, 63-70, 2017 | 7 | 2017 |
| Capacity-building for conducting COVID-19 vaccine effectiveness studies to enhance evidence-informed vaccination policymaking in the Eastern Mediterranean Region M Kheirandish, Z Karimian, K Fahmy, A Rashidian, R Hajjeh Special Edition on Evidence to Policy for Healthcare 29 (7-2023), 562, 2023 | 2 | 2023 |
| COVID-19 Vaccine Effectiveness Studies against Symptomatic and Severe Outcomes during the Omicron Period in Four Countries in the Eastern Mediterranean Region M Runge, Z Karimian, M Kheirandish, G Borghi, N Wodniak, K Fahmy, ... Vaccines 12 (8), 2024 | | 2024 |
| Shaping local health policies during health emergencies: insights from WHO COVID-19 vaccine effectiveness study in the Eastern Mediterranean Region Z Karimian, S Bellizzi, S Sirous, M Lukwiya, A Ahmed, K Fahmy, ... Eastern Mediterranean Health Journal (EMHJ) 30 (8), 539–541, 2024 | | 2024 |
| Surviving surgery; succumbing to pharmacotherapy: A case report underscoring the importance of PRN order clarification for patient safety S Nassiri, Z Karimian, K Tahermanesh, M Farasatinasab Journal of Healthcare Risk Management 42 (3-4), 40-44, 2023 | | 2023 |
| The Rational Use of Medicines (RUM) in Coronavirus Disease 2019 (COVID-19) Z Karimian Journal of Pharmaceutical Care, 52-54, 2021 | | 2021 |
| The Regulation of Clinical Trials in Iran–Challenges and Limitations Z Karimian Clin Res 6, 1-2, 2020 | | 2020 |
| Characterizing infusion reactions to intravenous enzyme replacement therapy: establishing temporal relationships for effective management strategies ZF Karimian, CB Whitley, JRJ Utz Abstracts/Molecular Genetics and Metabolism 117, S14-S124, 2016 | | 2016 |
| Immune tolerization to treat inhibitors to enzyme replacement therapy in Hunter syndrome using a non-immunosuppressing regimen JJ Utz, Z Karimian, CB Whitley Molecular Genetics and Metabolism 2 (117), S61-S62, 2016 | | 2016 |
